These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10316626)

  • 1. Quality assurance of drugs--the QUAD program.
    Leclerc-Chevalier D
    Drug Inf J; 1978; 12(1):23-5. PubMed ID: 10316626
    [No Abstract]   [Full Text] [Related]  

  • 2. Government as coordinator of drug information.
    Philbrook F
    Drug Inf J; 1978; 12(1):37-9. PubMed ID: 10316627
    [No Abstract]   [Full Text] [Related]  

  • 3. A drug defect reporting programme.
    Marigold W
    Can J Hosp Pharm; 1977; 30(5):140-1. PubMed ID: 10316502
    [No Abstract]   [Full Text] [Related]  

  • 4. QUAD routes out inferior drugs.
    Can Hosp; 1973 May; 50(5):58-9. PubMed ID: 4779804
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA-USP drug product problem reporting program--an update.
    Wheatley LS
    Hosp Formul; 1979 Mar; 14(3):359-60, 365. PubMed ID: 10316797
    [No Abstract]   [Full Text] [Related]  

  • 6. [Observations on drug quality and the QUAD program].
    Lalonde M
    Vie Med Can Fr; 1973 May; 2(5):497-502. PubMed ID: 4732209
    [No Abstract]   [Full Text] [Related]  

  • 7. Quality assurance for medical products: unified program for all federal agencies.
    Flaherty FJ
    Hosp Formul; 1976 Dec; 11(12):669, 674, 679. PubMed ID: 1028796
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug information and pharmaceutical quality control.
    Stroud RR
    Drug Inf J; 1978; 12(1):20-2. PubMed ID: 10308100
    [No Abstract]   [Full Text] [Related]  

  • 9. The Food and Drugs Act and quality assurance of pharmaceutical products.
    Allmark MG
    Med Serv J Can; 1967 Mar; 23(3):210-6. PubMed ID: 6056366
    [No Abstract]   [Full Text] [Related]  

  • 10. Controlling the quality of Uncle Sam's drugs.
    Hecht A
    FDA Consum; 1977 May; 11(4):22-3. PubMed ID: 10316531
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of essential drugs. Sixth report of the WHO Expert Committee.
    World Health Organ Tech Rep Ser; 1995; 850():1-137. PubMed ID: 7597816
    [No Abstract]   [Full Text] [Related]  

  • 12. Introduction to Quality Control in a Compounding Pharmacy.
    Allen LV
    Int J Pharm Compd; 2016; 20(6):481-484. PubMed ID: 28339387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 14. National drug quality assurance system.
    Wijesekera T
    Ceylon Med J; 1993 Jun; 38(2):58-60. PubMed ID: 8370088
    [No Abstract]   [Full Text] [Related]  

  • 15. [Information on the composition of chemical preparations for sale on the Belgian market].
    Arch Belg; 1988; 46(7-8):389-95. PubMed ID: 3269207
    [No Abstract]   [Full Text] [Related]  

  • 16. Proposed government role in drug information.
    Spino M
    Drug Inf J; 1978; 12(1):26-8. PubMed ID: 10308101
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug product quality as viewed by quality assurance personnel.
    Benney TL
    J Am Pharm Assoc; 1976 Nov; 16(11):601-2. PubMed ID: 977884
    [No Abstract]   [Full Text] [Related]  

  • 18. [Quality assurance is based on local conditions].
    Knudsen R
    Ugeskr Laeger; 1991 Apr; 153(14):1004-5. PubMed ID: 2024311
    [No Abstract]   [Full Text] [Related]  

  • 19. Communicating about drugs.
    Herman CM; Rodowskas CA
    Drug Inf J; 1976; 10(1):20-3. PubMed ID: 1029676
    [No Abstract]   [Full Text] [Related]  

  • 20. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organization Expert Committee
    World Health Organ Tech Rep Ser; 2010; (957):1-276, back cover. PubMed ID: 20560300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.